Certolizumab enhances spinal cord injury recovery in rats through inhibition of the TNF-α signaling pathway and neuronal apoptosis
Certolizumab treatment exerts a neuroprotective effect against secondary damage in SCI through the inhibition of neuroinflammation and apoptosis.
Authors
- Çevik Gürel (ORCID: https://orcid.org/0000-0003-0266-2115)
- Gökçe Ceren Kuşçu (ORCID: https://orcid.org/0000-0003-1750-8209)
- Seçil Arslansoyu Çamlar (ORCID: https://orcid.org/0000-0002-2402-0722)
- Ali Karadağ (ORCID: https://orcid.org/0000-0002-6280-8131)
- İnanç Karakoyun (ORCID: https://orcid.org/0000-0002-7057-171X)
- Murat Akşit (ORCID: https://orcid.org/0000-0003-2106-9130)
- Çağlar Türk (ORCID: https://orcid.org/0000-0002-2768-2801)
- Mustafa Eren Yüncü
- Ozan Küçükatalay
- Onur Sarıkaya
Institutions
- Izmir University (TR)
- Erzincan Binali Yıldırım University (TR)
- Ege University (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Harran University (TR)
Publication Details
- Journal
- Inflammopharmacology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1007/s10787-025-01674-5
- Citations
- 4
- Primary Topic
- Spinal Cord Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 5.89